New vaccine aims to stop deadly diarrhoea in kids
NCT ID NCT05987488
Summary
This study tested the safety and immune response of a new oral vaccine designed to prevent diarrhoea caused by Shigella and ETEC bacteria. It involved 196 healthy Bangladeshi adults and children, starting with adults and then moving to younger age groups. Participants received three doses of either the vaccine or a placebo to see how well it was tolerated and if it triggered protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)
Dhaka, Bangladesh
Conditions
Explore the condition pages connected to this study.